Charlene M. Fares
Hematology | Oncology
225 Smith Avenue North
Suite 200
Saint Paul, MN 55102
Suite 200
Saint Paul, MN 55102
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Phase II study of magrolimab combined with docetaxel in previously treated metastatic advanced solid tumors.
Journal: Frontiers in oncology
Published: January 12, 2026
Immune checkpoint inhibitor induced thyroid dysfunction is a frequent event post-treatment in NSCLC.
Immune checkpoint inhibitor induced thyroid dysfunction is a frequent event post-treatment in NSCLC.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: April 27, 2021
Osimertinib as neoadjuvant therapy in a patient with stage IIIA non-small cell lung cancer: a case report.
Journal: Journal of medical case reports
Published: August 21, 2020
Mutational landscape influences immunotherapy outcomes among patients with non-small-cell lung cancer with human leukocyte antigen supertype B44.
Journal: Nature cancer
Published: April 15, 2020
Association of PD-L1 expression by immunohistochemistry and gene microarray with molecular subtypes of ovarian tumors.
Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: February 22, 2020
Biomarkers that may predict response to immunotherapy in ovarian malignancies.
Journal: Current opinion in obstetrics & gynecology
Published: December 06, 2019
Mechanisms of Resistance to Immune Checkpoint Blockade: Why Does Checkpoint Inhibitor Immunotherapy Not Work for All Patients?
Journal: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting
Published: May 18, 2019
Low Concordance of Patient-Reported Outcomes With Clinical and Clinical Trial Documentation.
Journal: JCO clinical cancer informatics
Published: January 18, 2019
Showing 1-9 of 9
Last Updated: 09/26/2026